化合物IMR-1A T3540
品牌 | 厂商性质 | 产地 | 货期 |
---|---|---|---|
TargetMol | 生产商 | 美国 | 现货 |
性能特点
生化试剂,可用于动物细胞实验
规格 | CAS号 | 价格 | 操作 |
---|---|---|---|
25 mg | 331862-41-0 | ¥5,920.00 | 询底价 |
1 mL | 331862-41-0 | ¥2,550.00 | 询底价 |
500 mg | 331862-41-0 | ¥21,900.00 | 询底价 |
50 mg | 331862-41-0 | ¥8,180.00 | 询底价 |
1 mg | 331862-41-0 | ¥997.00 | 询底价 |
5 mg | 331862-41-0 | ¥2,450.00 | 询底价 |
10 mg | 331862-41-0 | ¥3,660.00 | 询底价 |
100 mg | 331862-41-0 | ¥10,800.00 | 询底价 |
Product Introduction
Bioactivity
英文名: IMR-1A
描述: IMR-1A 是 IMR-1 的酸代谢物。IMR-1A 是 Notch 抑制剂,IC50=0.5 μM。IMR-1A 相对于 IMR-1 的效力提高了 50 倍。
体外活性: IMR-1 prevents the recruitment of Maml1 to the NTC on chromatin, inhibits Notch target gene transcription, and dramatically inhibits tumor growth. A decrease in colony formation of Notch-dependent cell lines is observed upon treatment with IMR-1 when compared with the control (DMSO).
体内活性: The reference for intraperitoneal injection is 15 mg/kg. IMR-1 inhibits Notch-dependent somite development in zebrafish.
存储条件: Powder: -20°C for 3 years | In solvent: -80°C for 1 year
溶解度: DMSO : 4.23 mg/mL (13 mM)
关键字: Notch | Inhibitor | inhibit | IMR1A | IMR-1A | IMR 1A | Drug Metabolite
相关产品: BMS-983970 | Aβ42-IN-2 | FLI-06 | Demcizumab | Psoralidin | Carvacrol | Fosciclopirox | Gossypolone | 3,5-Bis(4-nitrophenoxy)benzoic acid | LY-411575
相关库: Anti-Neurodegenerative Disease Compound Library | Anti-COVID-19 Compound Library | Anti-Prostate Cancer Compound Library | Neuronal Differentiation Compound Library | Neuronal Signaling Compound Library | Inhibitor Library | Stem Cell Differentiation Compound Library | Covalent Inhibitor Library | Anti-Alzheimer's Disease Compound Library | Bioactive Compound Library
化合物IMR-1A T3540信息由TargetMol中国为您提供,如您想了解更多关于化合物IMR-1A T3540报价、型号、参数等信息,欢迎来电或留言咨询。
注:该产品未在中华人民共和国食品药品监督管理部门申请医疗器械注册和备案,不可用于临床诊断或治疗等相关用途